| Stage | CSCO | % of rev | ABBV | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $17.3B | 100.00% | $17.0B | 100.00% | CSCO ×1.02 |
| Gross profit | $11.1B | 64.13% | $12.4B | 73.03% | ABBV +8.9pp |
| Operating income | $4.3B | 24.72% | $6.4B | 37.86% | ABBV +13.1pp |
| Pre-tax income | $4.9B | 28.59% | $4.3B | 25.18% | CSCO +3.4pp |
| Net income | $3.9B | 22.37% | $3.6B | 21.28% | CSCO +1.1pp |
| Stage | CSCO | ABBV | Gap · A − B |
|---|---|---|---|
| Revenue | $17.3B100.00% | $17.0B100.00% | CSCO ×1.02 |
| Gross profit | 64.13%$11.1B | 73.03%$12.4B | ABBV +8.9pp |
| Operating income | 24.72%$4.3B | 37.86%$6.4B | ABBV +13.1pp |
| Pre-tax income | 28.59%$4.9B | 25.18%$4.3B | CSCO +3.4pp |
| Net income |
| 22.37%$3.9B |
| 21.28%$3.6B |
| CSCO +1.1pp |
No shared counterparties.